Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Notes Payables (2019 - 2025)

Rockwell Medical (RMTI) has disclosed Notes Payables for 7 consecutive years, with $462000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Notes Payables fell 1.49% year-over-year to $462000.0, compared with a TTM value of $462000.0 through Sep 2025, down 1.49%, and an annual FY2024 reading of $268000.0, up 9.84% over the prior year.
  • Notes Payables was $462000.0 for Q3 2025 at Rockwell Medical, down from $660000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $1.5 million in Q2 2022 and bottomed at $67000.0 in Q1 2025.
  • Average Notes Payables over 5 years is $630571.4, with a median of $495500.0 recorded in 2022.
  • The sharpest move saw Notes Payables increased 15.1% in 2022, then crashed 51.49% in 2023.
  • Year by year, Notes Payables stood at $437000.0 in 2021, then grew by 15.1% to $503000.0 in 2022, then plummeted by 51.49% to $244000.0 in 2023, then grew by 9.84% to $268000.0 in 2024, then surged by 72.39% to $462000.0 in 2025.
  • Business Quant data shows Notes Payables for RMTI at $462000.0 in Q3 2025, $660000.0 in Q2 2025, and $67000.0 in Q1 2025.